The discovery hinges on a classic piece of neural circuitry: the half-center oscillator. Engineers and neuroscientists have long known that two populations of neurons wired to inhibit each other can generate rhythm from nothing more than mutual antagonism. When one side fires, it suppresses the other; the suppressed side then escapes from inhibition, fires in its turn, and pushes its opponent back down. This arrangement powers the central pattern generators that control swimming, walking and breathing throughout the animal kingdom. The Oxford team has now shown that the same architecture, usually associated with movement, has been repurposed to regulate something as profound as the need for sleep.

To watch this circuit in action, the researchers implanted tiny translucent windows into the heads of living flies and used two-photon microscopy to image the calcium signals of dFBN dendrites over many minutes. What they saw was strikingly regular: fluorescence transients repeating rhythmically at 0.2 to 1 hertz, the frequency band that defines slow-wave activity. Simultaneous whole-cell patch-clamp recordings revealed the electrical events beneath these optical signals. The bistable neurons oscillated between depolarized UP states, during which they fired high-frequency bursts of action potentials, and hyperpolarized DOWN states, during which they fell silent. The alternation was metronome-like, mirroring the UP and DOWN membrane states that cortical neurons occupy during mammalian non-REM sleep.

Crucially, the slow rhythm did not arise from every cell in the ensemble, nor from cell-intrinsic pacemakers acting alone. When the team imaged individual dFBN somata within one hemisphere, their fluorescence traces were, on average, uncorrelated with one another. Instead, a handful of pacemaker-like neurons accounted for most of the variance in the compound dendritic signal. The real source of the rhythm emerged when the researchers imaged both brain hemispheres at once: the left and right dFBN populations oscillated in antiphase, each firing exactly when the other fell silent. Connectomic analysis of two independent electron-microscopy datasets, the hemibrain and FlyWire connectomes, confirmed that dFBNs are linked by dense, reciprocal, and almost perfectly symmetric connections, precisely the wiring diagram a half-center oscillator requires.

The neurotransmitter carrying this cross-hemispheric inhibition turned out to be glutamate, which is unusual because glutamate is best known as the brain’s main excitatory signal. In the fly central nervous system, however, glutamate frequently acts as an inhibitor. The researchers verified this assignment anatomically, using genetic intersection strategies that isolated dFBNs from other glutamatergic neurons, and functionally, with genetically encoded glutamate and acetylcholine sensors. When they optogenetically activated one random half of the dFBN mosaic, the other half hyperpolarized and stopped spiking, and this inhibition persisted in the presence of tetrodotoxin, proving that the connection is monosynaptic. dFBNs, in short, inhibit each other directly through inhibitory glutamatergic synapses.

Was this rhythm actually sufficient to put an animal to sleep? The team answered this with an elegant optogenetic replay experiment. Because stimulating both hemispheres in synchrony can drive the mutually inhibitory neurons into a depolarization block or a stalemate, earlier attempts to activate dFBNs had produced confusing results. Pulsed illumination, which mimics the natural burst structure, worked beautifully. When the researchers drove dFBNs with light patterns that reproduced naturalistic slow-wave activity, 500-millisecond bursts recurring at roughly 0.5 to 1 hertz, the flies went to sleep. The effect scaled with intraburst frequency up to a saturation point of about 40 hertz, matching the peak firing rates observed in spontaneous recordings. Tonic stimulation at the same average rate was far less effective, showing that the temporal structure of the signal, not just its intensity, carries the sleep instruction.

The necessity side of the argument was just as convincing. Depleting the vesicular glutamate transporter from dFBNs, or silencing them with potassium channels, reduced both baseline sleep and the rebound sleep that normally follows deprivation, all without hyperactivity or anatomical defects that might confound the interpretation. Sleep became fragmented, bouts shortened, and the slow oscillations themselves weakened. Interference with glutamatergic transmission thus dissolved both the rhythm and the behavior it was proposed to drive, tying the half-center oscillator directly to the homeostatic regulation of sleep.

Perhaps the most striking finding is that dFBN oscillations do not pause when the fly is awake. In mammals, slow waves are largely confined to deep sleep. In the fly, the team imaged head-fixed animals walking on a spherical treadmill and roused them with brief pulses of infrared heat aimed at the abdomen. The heat triggered dopamine release onto dFBN dendrites, locomotion, and a brief collapse of the calcium oscillations, but the rhythm quickly resumed through a powerful postinhibitory rebound. Slow-wave power in dFBNs rose with the duration of sleep deprivation, grew roughly linearly through the first half of the night, decayed over 12 to 24 hours of recovery, and followed a natural daily rhythm peaking in the evening. The oscillation therefore behaves as a continuous, amplitude-modulated readout of sleep pressure, streaming information about sleep need to downstream circuits even during waking, in a fly-mammalian inversion of convention.

How does the circuit tune its own gain? The answer is a surprising form of synaptic depression. Sleep deprivation is usually assumed to potentiate synapses, and indeed active zone markers like bruchpilot increase in most regions of the sleep-deprived fly brain. dFBNs do the opposite. Using genetic tagging of endogenous bruchpilot, the team showed that dFBN active zones shrink after sleep loss, and direct measurement of optically evoked glutamate release confirmed that transmission from dFBN synapses was attenuated. In a computational model of two reciprocally inhibitory dFBNs embedded in recurrent excitatory circuitry, this weakening was essential. Increased intrinsic excitability and stronger external drive raise slow-wave power only if the output synapses depress in parallel; without that homeostatic brake, the oscillating neurons would smother their own excitatory inputs. Two opposing forces, heightened excitability and weakened output, thus conspire to encode sleep need in the amplitude of the rhythm.

The broader picture is one of elegant engineering. dFBNs inherit their sleep pressure from a biochemical memory described in previous work, in which lipid peroxidation products oxidize the cofactor of the Shaker potassium channel’s Hyperkinetic subunit, one bit at a time. The half-center oscillator now provides the output stage: it converts that slowly accumulating chemical record into a periodic electrical signal whose amplitude tracks sleep need from moment to moment, resists the antagonism of arousing dopaminergic neurons in a flip-flop arrangement reminiscent of the mammalian hypothalamic sleep switch, and, when strong enough, tips the animal into sleep. The remaining puzzle is analog-to-digital conversion: sleep-wake states are binary, while the signal is graded. The authors suggest that strongly facilitating synapses or the winner-take-all architecture of the fan-shaped body could perform the transformation. Whatever the mechanism, the lesson is clear: the same rhythmic circuits that make legs move and hearts beat have been conscripted, over evolutionary time, to make brains rest.

Subject of Research: A half-center oscillator in Drosophila sleep-control neurons that generates slow-wave activity encoding and regulating sleep pressure

Article Title: A half-center oscillator regulates sleep pressure

Article References: Hasenhuetl, P. S., Sarnataro, R., Vrontou, E., Rorsman, H. O., Talbot, C. B., Brain, R., & Miesenböck, G. (2026). A half-center oscillator regulates sleep pressure. Nature Neuroscience. https://doi.org/10.1038/s41593-026-02431-9

Image Credits: AI Generated

DOI: 10.1038/s41593-026-02431-9

Keywords: sleep pressure, half-center oscillator, slow-wave activity, Drosophila, dorsal fan-shaped body, glutamatergic transmission, optogenetics, sleep homeostasis, synaptic depression, two-photon imaging, connectomics, neural oscillations

To understand the stakes, it helps to know what the slow-wave slope actually is. During deep non-REM sleep, the cerebral cortex generates large, synchronized oscillations known as slow waves, each consisting of a hyperpolarized down state followed by a depolarized up state. When these waves are averaged across many electrodes in high-density electroencephalography, their rising and falling edges have measurable steepness, or slope. According to the influential synaptic homeostasis hypothesis, slow-wave slope tracks the strength of synaptic connections built up during waking experience: steeper slopes early in the night are thought to reflect high synaptic strength and high sleep pressure, while slopes become progressively shallower as sleep-dependent downscaling proceeds. In their original study, drawing on data from the Wisconsin Sleep Cohort, Maganti’s team found that individuals with severe obstructive sleep apnea failed to show the normal overnight decline in slow-wave slope, which they interpreted as evidence of disrupted sleep homeostasis.

Huang and Shen raised several objections. First, they noted that scalp-recorded slow-wave slope is not a pure readout of synaptic dynamics. Structural brain abnormalities, such as the white matter injury and cortical changes documented in patients with obstructive sleep apnea, could alter how neuronal signals synchronize and propagate, distorting the slope measurement without any change in synaptic strength. Second, they suggested that the absence of an overnight decline in the severe apnea group might simply be a floor effect: if slope values were already compressed near the bottom of their possible range, there would be little room left for them to fall further during the night. Third, they questioned whether the analysis was contaminated by mathematical coupling between the slope measure and other variables derived from the same slow-wave activity data.

In their reply, Maganti, Wang, and Hetzel conceded the first point gracefully. They acknowledged that scalp EEG-derived slow-wave slope is not an exclusive marker of synaptic dynamics and that physiological and structural factors can influence the measurement. They pointed to prior neuroimaging work showing widespread structural brain abnormalities in obstructive sleep apnea, including white matter injury and cortical changes, which may plausibly alter neuronal synchronization and signal propagation. They also reasoned that any distortion caused by a fixed structural abnormality would likely persist throughout the night, contributing in part to the altered slow-wave characteristics recorded at the scalp. Importantly, they admitted that the lack of neuroimaging in their cohort was a genuine limitation of the study, an admission that lends credibility to the rest of their defense.

The floor-effect objection, however, they rejected on statistical grounds, and the numbers they provide make a compelling case. A floor effect of the kind the critics proposed would require a substantial fraction of participants, more than fifteen percent according to established measurement-quality criteria, to cluster near the theoretical threshold of zero slope. Yet the group means in the original study ranged from 214.2 to 219.3, with standard deviations consistently around 25.0. Even more tellingly, the minimum values observed across the groups ranged from 130 to 165, far above zero. In other words, no participant came anywhere close to a floor, leaving ample room for slopes to decline overnight had homeostatic downscaling been operating normally. The authors argue that the flat overnight trajectory in severe apnea is therefore more consistent with genuinely impaired sleep homeostasis than with a measurement ceiling or floor artifact.

The mathematical coupling critique was dispatched with equal precision. The slow-wave decay slope in the study was estimated by regressing hourly mean slow-wave activity over time for each participant. Because the slope of these hourly means is not directly linked to the slope of slow-wave measures taken specifically during the first hour of non-REM sleep, the two variables are not mathematically coupled in the way the critics feared. This distinction matters, because mathematical coupling can manufacture spurious correlations when two quantities share a common component, and ruling it out strengthens the claim that the observed relationships reflect real physiology rather than statistical circularity.

Beyond rebutting the specific objections, the reply situates slow-wave slope within a broader experimental tradition. The authors cite a seminal high-density EEG study in humans demonstrating that slow-wave slope is tightly linked to sleep homeostatic pressure, decreasing across the night as the need for sleep dissipates. They also point to complementary work using cortical recordings and local field potentials in animal models, which showed that slow-wave characteristics, including slope, track sleep-wake history and reflect underlying changes in synaptic strength associated with wake-dependent potentiation and sleep-dependent downscaling. Taken together, these studies provide direct electrophysiological evidence that the slope of the slow wave is not an arbitrary feature of the EEG trace but a meaningful indicator of the brain’s synaptic economy.

Perhaps the strongest card in the authors’ hand, however, is convergence. Their original conclusions did not rest on slow-wave slope alone. They observed attenuated overnight decay of slow-wave activity, a separate and well-established homeostatic marker, alongside altered relationships between wake after sleep onset and subsequent slow-wave activity. When multiple independent measures of sleep homeostasis point in the same direction, the authors argue, a single methodological explanation becomes increasingly implausible. The consistency of these findings across complementary metrics supports the broader conclusion that severe obstructive sleep apnea is associated with impaired sleep homeostasis, a conclusion with real clinical weight given that sleep homeostasis is thought to underpin the restorative functions of sleep, from memory consolidation to metabolic regulation.

The exchange ends on a constructive note that reflects how science ideally negotiates its uncertainties. Maganti and colleagues express appreciation for the insightful comments of Huang and Shen and agree that future studies combining polysomnography, advanced neuroimaging, and multimodal neurophysiological biomarkers will be essential for disentangling the relative contributions of structural brain alterations and synaptic dysregulation to the sleep homeostasis abnormalities seen in obstructive sleep apnea. The underlying polysomnography data from the Wisconsin Sleep Cohort are available through the National Sleep Research Resource, and the analysis scripts will be shared on reasonable request, an openness that should accelerate exactly the kind of follow-up work both sides call for. For now, the debate serves as a vivid reminder that even the humblest features of the sleeping brain, the slope of a wave rippling across the cortex a few times a minute, can carry profound information about how the organ maintains itself, and that defending that information against methodological doubt is part of the daily work of sleep science.

Subject of Research: Slow-wave slope as a marker of synaptic homeostasis in obstructive sleep apnea

Article Title: Reply to “Methodological caveats in interpreting slow-wave slope as a marker of synaptic homeostasis in OSA”

Article References: Maganti, R., Wang, J., & Hetzel, S. (2026). Reply to “Methodological caveats in interpreting slow-wave slope as a marker of synaptic homeostasis in OSA”. Journal of Clinical Sleep Medicine, 22(1), Article 195. https://doi.org/10.1007/s44470-026-00203-7

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00203-7

Keywords: slow-wave slope, sleep homeostasis, obstructive sleep apnea, synaptic homeostasis hypothesis, EEG, Wisconsin Sleep Cohort, non-REM sleep, slow-wave activity, neuroimaging, polysomnography, synaptic plasticity, Journal of Clinical Sleep Medicine

Scientists call this process sleep homeostasis, and it is one of the two great forces that govern when and how deeply we sleep, the other being the circadian clock. The longer we stay awake, the stronger the pressure for sleep becomes, and the classic fingerprint of that pressure is slow wave activity, the high-amplitude, low-frequency electrical waves that dominate deep non-REM sleep. In a healthy sleeper, slow wave activity is ferocious in the first NREM episode of the night and then decays steadily across successive sleep cycles, like a battery discharging as it refills. By morning, the pressure is gone. According to the influential synaptic homeostasis hypothesis, this overnight decline is not merely a byproduct of sleep but its central purpose: synapses strengthened by the day’s experience are progressively downscaled, restoring energy balance, consolidating memories, and preparing the cortex to learn again.

Lead author Rama Maganti of the University of Wisconsin School of Medicine and Public Health and colleagues asked a deceptively simple question: does this decay still work properly in people with obstructive sleep apnea, and does it get worse as the disease gets more severe? To find out, they mined polysomnography records from 945 participants in the Wisconsin Sleep Cohort, each contributing their first sleep study, collected between 1988 and 2015. Participants were divided into four groups by apnea-hypopnea index: no apnea (430 people), mild (267), moderate (120), and severe (128). Rather than relying on a single crude measure, the team quantified sleep homeostasis three independent ways: the decay of normalized slow wave activity across the night’s NREM episodes, the change in the slope of individual slow waves from the first to the last hour of sleep, and the brain’s ability to compensate with extra slow wave activity after episodes of wakefulness.

The technical execution matters here. The researchers extracted delta-band power, between 0.5 and 4 hertz, from frontal and central EEG electrodes in every 6-second epoch of N2 and N3 sleep, then normalized it against power in the theta, alpha, beta, and sigma bands to strip out individual differences in overall signal. Slow wave slopes were computed automatically by detecting zero-crossings on the filtered signal, isolating the descending segments of negative half-waves, and dividing amplitude by duration. It is a level of granularity that earlier apnea studies, which mostly tracked absolute delta power alone, never attempted. The result is the most systematic portrait to date of how sleep pressure regulation behaves across the full spectrum of sleep-disordered breathing.

The headline finding is stark. In people without apnea, and in those with mild or moderate disease, slow wave activity fell significantly between the first and fourth NREM episode of the night. In the severe apnea group, that decline vanished. The flattening of the decay curve tracked the apnea-hypopnea index across the whole cohort: the higher the AHI, the flatter the discharge of sleep pressure. Slow wave slopes told the same story. In every group except severe apnea, the slope of individual slow waves dropped significantly from the first to the last hour of NREM sleep, the expected signature of synaptic renormalization. In severe disease, the slopes barely budged, as if the brain never got the signal that its cleanup work was done. Notably, average slow wave activity itself was identical across groups, which means the pathology hides not in how much slow wave activity a person shows, but in how it moves through the night.

Fragmentation emerged as the likely culprit. Wake after sleep onset, the minutes of intrusive wakefulness scattered through the night, was strongly associated with flatter decay, and the relationship was steepest in the severe group. The study also uncovered a striking sex difference: for any given level of slow wave decay, men showed higher apnea indices than women, hinting that males may be more vulnerable to the homeostatic consequences of each respiratory event. The authors suggest that the repeated arousals triggered by airway collapse, sometimes dozens of times per hour, prevent the continuous stretches of deep sleep that the homeostatic process needs to run its course, leaving sleep pressure only partially discharged by morning.

Perhaps the most surprising chapter of the study concerns what happens outside the airway. In multivariable models adjusting for age, sex, and body mass index, several clinical factors independently predicted impaired sleep homeostasis. Diabetes was associated with flatter slow wave slopes. So were antidepressant medications, anti-anxiety drugs, antihypertensives, sedatives, and heavy caffeine intake of more than four beverages a day. When the team dissected antidepressant classes, tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors showed the strongest and most persistent associations with disrupted slow wave decay, even after covariate adjustment, while SSRIs, bupropion, and benzodiazepines did not reach significance. On the protective side, the percentage of N3 deep sleep showed a robust graded relationship with healthier homeostatic dynamics: participants with more than 12 percent N3 sleep had dramatically steeper slow wave slopes than those with almost none. Sleep homeostasis, in other words, is not simply a casualty of apnea severity but a system shaped by metabolism, pharmacology, and sleep architecture all at once.

Why should a flattened decay curve matter for health? The authors point to a growing body of evidence linking disrupted slow wave dynamics to the worst outcomes of sleep apnea. Sleep homeostasis is thought to be essential for synaptic downscaling, memory consolidation, and neuroplasticity, and disturbances in slow wave activity have been tied to deficits in attention, executive function, and working memory in apnea patients. Reduced slow wave activity and fragmented non-REM sleep are also associated with impaired glymphatic clearance of beta-amyloid, the protein that accumulates in Alzheimer’s disease, and one prior study found that amyloid levels fell and slow wave activity rose after treatment with CPAP. More ominously, a recent longitudinal study showed that a disrupted overnight dissipation of delta activity predicts all-cause mortality, and loss of slow wave decay has been documented in people who died of sudden unexpected death in epilepsy. Flattened sleep pressure dynamics may thus be a mechanistic bridge between a collapsing airway and the cardiovascular, cognitive, and mortal consequences that follow.

The study has honest limitations. It is observational, drawn from a single predominantly white cohort of middle-aged adults, so causation and generalizability remain open questions. Medication use was self-reported, standard EEG leads cannot reveal regional slow wave changes that high-density arrays might capture, and the researchers did not compare homeostatic measures before and after CPAP initiation, leaving the reversibility of the damage untested. Still, the implications are provocative. If severe apnea leaves the brain unable to discharge sleep pressure, patients may experience nonrestorative sleep even when they spend enough hours in bed, and treatments aimed solely at eliminating breathing pauses may not fully restore the underlying regulatory process. The authors argue that future trials should test whether CPAP reverses these impairments, and whether therapies should be designed to correct sleep homeostasis itself, not just the airway. For the hundreds of millions of people worldwide who stop breathing in their sleep, the deepest cost of the disease may be a brain that wakes each morning still owing the debt of the night before.

Subject of Research: Impairment of sleep homeostasis and slow wave activity dynamics across obstructive sleep apnea severity

Article Title: Sleep homeostasis impairment across obstructive sleep apnea severity: findings from a population-based cohort study

Article References: Maganti, R., Wang, J., & Hetzel, S. (2026). Sleep homeostasis impairment across obstructive sleep apnea severity: findings from a population-based cohort study. Journal of Clinical Sleep Medicine, 22(1), Article 134. https://doi.org/10.1007/s44470-026-00131-6

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00131-6

Keywords: obstructive sleep apnea, sleep homeostasis, slow wave activity, polysomnography, NREM sleep, apnea-hypopnea index, sleep fragmentation, synaptic downscaling, antidepressants, deep sleep, Wisconsin Sleep Cohort, cognitive decline

The commentary, authored by Sasikanth Gorantla of the Emory University School of Medicine, Katyayini Aribindi of the University of California, Davis, and Vishesh K. Kapur of the University of Washington School of Medicine, responds to a population-based cohort study showing that sleep homeostasis is impaired across the full spectrum of obstructive sleep apnea severity. That finding, the authors contend, elevates sleep homeostasis from an abstract concept of sleep science to a measurable clinical signal, one that could reshape how researchers and physicians evaluate the burden of the disease and the success of its treatment.

Sleep homeostasis is one half of the classic two-process model of sleep regulation, first articulated by Alexander Borbély in 1982. The model holds that sleep timing and depth are governed by the interaction of a circadian process, which rhythms sleep and wakefulness across the day, and a homeostatic process, an hourglass-like accumulation of sleep need that builds during waking hours and dissipates during sleep. The electrophysiological signature of this homeostatic process is most visible in the electroencephalogram as slow-wave activity, the low-frequency delta power that dominates deep non-REM sleep and declines progressively across a night of rest.

Decades of research in animal models and humans have established that this slow-wave signature is not merely a byproduct of sleep but a reflection of genuine neurophysiological work. Studies of freely behaving rats by Vyazovskiy, Cirelli and Tononi demonstrated that the electrophysiological correlates of sleep homeostasis are tightly linked to the duration of prior wakefulness. The influential synaptic homeostasis hypothesis proposed by Tononi and Cirelli goes further, suggesting that slow-wave activity during sleep actively downscales synapses strengthened during wakefulness, protecting neural circuits from saturation and preserving the brain’s capacity for plasticity, learning and memory consolidation.

Against this backdrop, the notion that obstructive sleep apnea disrupts sleep homeostasis takes on considerable significance. The disorder fragments sleep with repeated collapses of the upper airway, each accompanied by oxygen desaturation and an arousal that shatters the continuity of deep sleep. But the commentary emphasizes that the damage is not simply a matter of sleep loss. The recurring hypoxic and ventilatory stresses of apnea appear to interfere with the very mechanisms that generate and dissipate homeostatic sleep pressure, leaving patients with a brain that has neither slept deeply enough nor recovered adequately, even after nights that seem, on paper, to contain sufficient hours of sleep.

Recent landmark studies have already shown why conventional indices fall short. The hypoxic burden of sleep apnea, a measure of the severity of oxygen deprivation rather than the frequency of breathing events, predicted cardiovascular disease-related mortality in large cohorts including the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study. Similarly, ventilatory burden, which quantifies the respiratory effort expended against a collapsed airway, proved predictive of cardiovascular and all-cause mortality in work published in the American Journal of Respiratory and Critical Care Medicine. These alternative measures capture physiological stress that the apnea-hypopnea index misses, and sleep homeostasis, the commentary argues, belongs squarely in this emerging family of clinically meaningful severity markers.

The implications for treatment evaluation are particularly striking. Continuous positive airway pressure, the standard therapy for obstructive sleep apnea, has produced famously mixed results in trials of neurocognitive outcomes, including the large APPLES study, and real-world registry data on its effect on sleepiness reveal variable benefit. The commentary notes that sleep architecture impairment and cognitive performance vary substantially across apnea phenotypes, and that conventional polysomnographic outcomes may be too blunt to detect which patients genuinely recover restorative sleep under therapy. Quantifying slow-wave activity and other markers of homeostatic sleep regulation could provide a sensitive readout of whether treatment is actually restoring the brain’s recovery processes, not merely eliminating respiratory events.

The commentary also situates sleep homeostasis within a broader neurophysiological context. Recent imaging work in humans has revealed coupled electrophysiological, hemodynamic and cerebrospinal fluid oscillations during sleep, suggesting that slow-wave activity coordinates a large-scale clearance and restoration program in the brain. Pharmacological studies complicate the picture further: caffeine reduces low-frequency delta activity in the sleep EEG, benzodiazepines such as temazepam alter slow waves in ways that do not necessarily restore normal homeostatic function, and antidepressants including fluoxetine and trazodone reshape sleep architecture with distinct effects on slow-wave activity. Any clinical use of sleep homeostasis as an outcome measure will therefore need to account for these pharmacological and physiological confounders.

For the field of sleep medicine, the commentary’s central message is one of expansion rather than replacement. The apnea-hypopnea index remains useful for diagnosis and disease classification, but it was never designed to capture the neurophysiological consequences of the disorder. Sleep homeostasis, measurable through standard EEG recordings and increasingly through high-density and quantitative EEG techniques, offers a patient-centered, mechanism-based outcome that aligns with what patients and clinicians ultimately care about: whether the brain is recovering night after night. If validated in prospective trials, this measure could help stratify patients, personalize therapy and provide a more faithful endpoint for the next generation of apnea treatments.

The work received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. As sleep researchers continue to refine how obstructive sleep apnea is defined and staged, the humble delta wave, once an academic curiosity of sleep physiology, may prove to be one of the most informative signals a clinician can read from a sleeping patient’s brain, a direct measure of the homeostatic machinery that obstructive sleep apnea quietly wears down.

Subject of Research: Sleep homeostasis as a neurophysiological outcome measure in obstructive sleep apnea

Article Title: Sleep homeostasis in OSA: a complementary neurophysiological outcome measure

Article References: Gorantla, S., Aribindi, K., & Kapur, V. K. (2026). Sleep homeostasis in OSA: a complementary neurophysiological outcome measure. Journal of Clinical Sleep Medicine, 22(1), Article 157. https://doi.org/10.1007/s44470-026-00174-9

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00174-9

Keywords: obstructive sleep apnea, sleep homeostasis, slow-wave activity, two-process model, EEG delta power, apnea-hypopnea index, hypoxic burden, ventilatory burden, CPAP treatment, synaptic homeostasis hypothesis, sleep architecture, cognitive performance